Garcia-Rill E, Hyde J, Kezunovic N, Urbano F J, Petersen E
Department of Neurobiology and Developmental Sciences, Center for Translational Neuroscience, University of Arkansas for Medical Sciences, Slot 847, 4301 West Markham St, Little Rock, AR, 72205, USA,
J Neural Transm (Vienna). 2015 Feb;122(2):225-35. doi: 10.1007/s00702-014-1243-x. Epub 2014 Jun 1.
This brief review resolves a number of persistent conflicts regarding the location and characteristics of the mesencephalic locomotor region, which has in the past been described as not locomotion-specific and is more likely the pedunculopontine nucleus (PPN). The parameters of stimulation used to elicit changes in posture and locomotion we now know are ideally suited to match the intrinsic membrane properties of PPN neurons. The physiology of these cells is important not only because it is a major element of the reticular activating system, but also because it is a novel target for the treatment of gait and postural deficits in Parkinson's disease (PD). The discussion explains many of the effects reported following deep brain stimulation (DBS) of the PPN by different groups and provides guidelines for the determination of long-term assessment and effects of PPN DBS. A greater understanding of the physiology of the target nuclei within the brainstem and basal ganglia, amassed over the past decades, has enabled increasingly better patient outcomes from DBS for movement disorders. Despite these improvements, there remains a great opportunity for further understanding of the mechanisms through which DBS has its effects and for further development of appropriate technology to effect these treatments. We review the scientific basis for one of the newest targets, the PPN, in the treatment of PD and other movement disorders, and address the needs for further investigation.
这篇简短的综述解决了一些关于中脑运动区位置和特征的长期争议,中脑运动区过去被描述为并非运动特异性的,而更有可能是脚桥核(PPN)。我们现在知道,用于引发姿势和运动变化的刺激参数非常适合匹配PPN神经元的内在膜特性。这些细胞的生理学不仅重要,因为它是网状激活系统的主要组成部分,还因为它是治疗帕金森病(PD)步态和姿势缺陷的新靶点。该讨论解释了不同研究小组对PPN进行深部脑刺激(DBS)后报告的许多效应,并为PPN-DBS的长期评估和效应测定提供了指导。在过去几十年中积累的对脑干和基底神经节内目标核生理学的更深入理解,使得DBS治疗运动障碍的患者预后越来越好。尽管有这些改进,但仍有很大机会进一步了解DBS产生效果的机制,并进一步开发实施这些治疗的合适技术。我们综述了治疗PD和其他运动障碍的最新靶点之一——PPN的科学依据,并探讨了进一步研究的需求。